125 Potential Immunological Triggers for Central Disorders of Hypersomnolence Appendix C All between-groups immunological event comparisons in the full sample Supplementary Table 3: All between-group immunological event comparisons Variable Narcolepsy type 1 (N = 194) Narcolepsy type 2 or idiopathic hypersomnia (N = 71) Odds ratio (95% CI) Effect size Corrected p-value Infections & influenza vaccinations N Percentage of N N Percentage of N Total immunological event prevalence 194 44.8% 71 50.7% 0.79 (0.46-1.36) 0.0520 0.5073 Distribution of immunological events 90 Flu: 14.4% EBV: 13.3% Other respiratory infection: 11.1% Other nonrespiratory infections: 12.2% H1N1 influenza vaccination: 36.7% Other years/ unspecified yearly: 12.2% 37 Flu: 5.4% EBV: 27.0% Other respiratory infection: 21.6% Other nonrespiratory infections: 21.6% H1N1 influenza vaccination: 5.4% Other years/ unspecified yearly: 18.9% - 0.3797 0.0193 4
RkJQdWJsaXNoZXIy MjY0ODMw